NCT04071405View on ClinicalTrials.gov

Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

September 26, 2022

Study Completion Date

September 26, 2022

Conditions
Ulcerative Colitis
Interventions
OTHER

Non-intervention

Non-intervention observational study

Trial Locations (1)

Unknown

Pfizer, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04071405 - Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients | Biotech Hunter | Biotech Hunter